Navigation Links
Ziosoft Announces the Appointment of Rob Royea, Vice President, Sales and Marketing
Date:11/18/2009

Royea joined Ziosoft effective November 16, 2009.

(PRWEB) November 18, 2009 -- Ziosoft®, Inc. http://www.ziosoftinc.com -- a leader in advanced visualization and analysis software for medical imaging, today announced that Rob Royea has joined Ziosoft as vice president, sales and marketing, effective November 16.

Most recently, Royea served as vice president of worldwide sales for Eklin Medical Systems. Prior to Eklin, Royea held various leadership positions at AGFA Healthcare, Siemens Medical Solutions and Acuson (prior to its acquisition by Siemens). Royea brings over 25 years of experience in diagnostic imaging, PACS and medical informatics companies, ranging from large, global corporations to early stage start-up firms.

“Rob’s strategic leadership in the U.S., Europe and the Middle East is going to be a great asset to Ziosoft as we move forward in strengthening our position in the marketplace,” said Kazuhiko Matsumoto, chief executive officer of Ziosoft. His successful track record and extensive experience in managing global sales and marketing organizations brings a critical capability to Ziosoft and will complement our strategic vision for the company.“

With highly sophisticated 3D advanced visualization software, Ziosoft offers unlimited diagnostic potential at virtually any location. With over 2,000 systems installed worldwide, the Ziostation thin-client system is revolutionizing the way clinicians access, analyze and share the information required for optimal clinical care. With the Company’s end-to-end product integration, every component integrates efficiently, providing industry-leading performance in an economically sensible package. In addition, scalability is central to Ziosoft's product structure. Hospitals are guaranteed long-term investment value with the interoperability of the entire product line while underlying technologies are engineered to scale seamlessly, from one 3D workstation to hundreds.

“The ability to provide clinicians with state-of-the-art visualization tools in support of superior patient care is a very exciting opportunity,” said Royea. “Ziosoft not only offers superb visualization technology, but also it does so at a very economical performance-to-value ratio. I look forward to working with the Ziosoft team to provide further innovations leading to greater diagnostic confidence.”

About Ziosoft, Inc.
Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit physicians, patients, and healthcare specialists. Founded in 1998, Ziosoft is a leading independent advanced visualization company with over 2,000 installed systems in over 800 sites worldwide. Ziosoft is dedicated to providing intelligent and intuitive clinical tools across the enterprise. Ziosoft is a privately held company with locations in Redwood City, CA, Brussels, Belgium, and Tokyo, Japan. For more information, please visit http://www.ziosoftinc.com.

###

Read the full story at http://www.prweb.com/releases/2009/11/prweb3224794.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Medicsight Announces New Global Marketing Partnership with Ziosoft Unveiled at RSNA 2008
2. Ziosoft Receives FDA Clearance for CT Brain Perfusion Application
3. Ziosoft and Global Imaging Online Announce Reseller Agreement for France and Maghreb Area
4. Ziosoft Announces Agreement with Imaging & Medical Information Technology to Distribute Ziosoft's 3D Advanced Visualization Software in Turkey
5. Ziosoft Will Showcase New Clinical Functionality and Workflow Optimization Tools for Its Advanced 3D Thin-Client Software at RSNA 2009
6. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
7. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
8. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
9. HEI, Inc. Announces Sale of RFID Division Assets
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Ziosoft Announces the Appointment of Rob Royea, Vice President, Sales and Marketing
(Date:1/23/2017)... ... 23, 2017 , ... The Masters of Science in Healthcare ... with decades of experience who remain current practitioners in the field. With the ... is a renewed demand for versatile, data-driven leadership.The American University’s MS in Healthcare ...
(Date:1/23/2017)... ... 23, 2017 , ... METTLER TOLEDO has announced the availability ... Simple PAT Tools . , Crystallization is a common step used ... Chemists now spend more time developing better intermediate and final crystallization steps. ...
(Date:1/23/2017)... ... January 23, 2017 , ... Old School Labs™, makers ... Mr. Olympia Classic Physique bodybuilder Breon Ansley to its growing team of brand ambassadors. ... bodybuilder in 2012 and in less than a year was able to turn professional, ...
(Date:1/23/2017)... ... January 23, 2017 , ... “Crossing the Bar”: a moving ... a woman’s life. “Crossing the Bar” is the creation of published author, Charlotte Hotte, ... , Charlotte, who credits the inspiration of the book to her sister, Denise, wishes ...
(Date:1/23/2017)... ... January 23, 2017 , ... Valentine’s Day is a time when many people celebrate romance ... those who may be looking for the ideal present, Atlanta-based Perimeter Plastic Surgery ... additional $25 free. Or, spend $200 and get $50 free. , “A lot of ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... -- The global  anxiety disorders and depression treatment market  is expected ... of depression worldwide is anticipated to drive the market growth in the coming ... for antidepressants in the recent years. Continue Reading ... ... ...
(Date:1/23/2017)... , Jan 23, 2017 NeuroVive Pharmaceutical ... has signed a preclinical collaboration agreement with the Children,s Hospital ... J. Falk , M.D., a US key opinion leader in ... ... will evaluate compounds from NeuroVive,s research program, NVP015, in certain ...
(Date:1/21/2017)... Research and Markets has announced the ... Type of Test (Tumor, Clinical Chemistry, Microbiology, Esoteric), By Type ... (Tuberculosis, Influenza, Cancer, HIV/AIDS etc.), Forecast to 2022" report ... ... market segments, especially clinical lab testing, which has evolved as ...
Breaking Medicine Technology: